Canada's Kits Eyecare prelim Q4 revenue growth tops estimates

Kits Eyecare

07/01/2026 12:09

Overview

Canada eyecare provider's preliminary Q4 revenue rose 20%, beating analyst expectations

Glasses revenue for Q4 grew 33% yr/yr

Company's full-year 2025 revenue increased 27% yr/yr

Outlook

Kits Eyecare did not provide specific future guidance

Result Drivers

GLASSES REVENUE - Record Q4 glasses revenue increased 33% yr/yr to C$8.7 mln, driven by higher unit sales

UNIT SALES GROWTH - Glasses units increased 43% yr/yr to 119,000 units, supporting revenue growth

NEW CUSTOMERS - New customer additions increased 30% yr/yr to 393,000, boosting overall revenue

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
C$53.90 mln
C$52.67 mln (5 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"

Wall Street's median 12-month price target for Kits Eyecare Ltd is C$23.00, about 19.7% above its January 6 closing price of C$19.22

The stock recently traded at 69 times the next 12-month earnings vs. a P/E of 60 three months ago

Press Release: ID:nCNWBfW88a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)